VC-backed Mirum Pharmaceuticals debuts IPO
Foster City, California-based Mirum Pharmaceuticals, a clinical-stage therapeutics company focused on treating cholestatic liver diseases, has raised $75 million for its IPO after pricing its 5 million shares at $15 per share. The stock began trading July 18, 2019 on the NASDAQ under the ticker symbol "MIRM." Citigroup, Evercore ISI and Guggenheim Securities are the lead underwriters. Mirum's pre-IPO backers included NEA, Deerfield Management, Frazier Healthcare Partners, Novo Holdings, Pappas Capital, RiverVest Venture Partners and Rock Springs Capital.
18 July 2019•2 mins read
